Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor
Crossref DOI link: https://doi.org/10.1186/s12885-015-1975-5
Published Online: 2015-12-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nishimura, Toshio
Nakamura, Kazuto
Yamashita, Soichi
Ikeda, Sadatomo
Kigure, Keiko
Minegishi, Takashi